NASDAQ:BLUE
bluebird bio Stock News
$0.92
-0.0522 (-5.35%)
At Close: Jul 02, 2024
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Bluebird bio Inc. (NASDAQ: BLUE)
Blue Thunder Mining Inc. Appoints Alain Levesque CFO; Announces Board Change
07:00am, Tuesday, 25'th Jun 2024
Montreal, Quebec--(Newsfile Corp. - June 25, 2024) - Blue Thunder Mining Inc. (TSXV: BLUE) ("Blue Thunder" or the "Company") announces that Alain Lévesque will be joining the Company's management tea
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
03:27pm, Monday, 17'th Jun 2024
Biotech stocks operate under a core ethos. While there's been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals – when you think about it, nothing
Both Top Independent Proxy Advisors Recommend “FOR” Medallion's Nominees and Executive Compensation Both Top Independent Proxy Advisors Recommend “FOR” Medallion's Nominees and Executive Compe
Blue Thunder Mining Inc. Changing Name to Orbec Gold Mines Inc., Moving Headquarters to Brossard, Quebec
07:00am, Tuesday, 04'th Jun 2024
Montreal, Quebec--(Newsfile Corp. - June 4, 2024) - Blue Thunder Mining Inc. (TSXV: BLUE) ("Blue Thunder" or the "Company") announces that as of its Annual General Meeting to be held on June 6, 2024,
2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
10:15pm, Sunday, 02'nd Jun 2024
CHICAGO , June 2, 2024 /PRNewswire/ -- 2Flo Ventures, an emerging venture capital firm and startup studio focused on the discovery, development, and commercialization of healthcare solutions that add
BLUE OWL CAPITAL ANNOUNCES PRICING OF SENIOR NOTES OFFERING
05:25pm, Thursday, 30'th May 2024
NEW YORK , May 30, 2024 /PRNewswire/ -- Blue Owl Capital Inc. ("Blue Owl") (NYSE: OWL) today announced the pricing of the offering of $250,000,000 of 6.250% Senior Notes due 2034 (the "notes") by Blue
Bluebird bio appoints new CFO to oversee financial restatements
08:56am, Wednesday, 29'th May 2024
Gene therapy maker bluebird bio on Wednesday named former Renalytix finance chief James Sterling as its CFO to oversee the revision of the company's financial statements.
bluebird bio Appoints O. James Sterling as Chief Financial Officer
07:00am, Wednesday, 29'th May 2024
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that O. James Sterling, has been appointed chief financial officer (CFO), effective June 10, 2024. Mr. Sterling mo
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board's Director Nominees on the BLUE Proxy Card
07:30am, Tuesday, 28'th May 2024
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Medallion Financial Corp. (NASDAQ: MFIN) (“Medallion” or the “Company”) today announced that leading independent proxy advisory firm Institutional Sh
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming May 28, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Lawsuit - BLUE
05:45am, Thursday, 23'rd May 2024
NEW YORK , May 23, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ: BLUE) of a class action securities lawsuit. CLASS DEFI
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUE
02:20pm, Wednesday, 22'nd May 2024
NEW YORK , May 22, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE). Such investors ar
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
11:00am, Wednesday, 22'nd May 2024
BENSALEM, Pa. , May 22, 2024 /PRNewswire/ -- Law Offices of Howard G.
Investors in bluebird bio, Inc. Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUE
05:45am, Tuesday, 21'st May 2024
NEW YORK , May 21, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of bluebird bio, Inc. (NASDAQ: BLUE). Shareholders who purchased shares of BLUE during the class